Interaction Risks and Consequences
Lipitor (atorvastatin), a widely prescribed cholesterol-lowering medication, has been reported to interact with opioid painkillers, potentially leading to adverse effects and increasing the risk of kidney damage [1].
Why are these interactions concerning?
When taken together, Lipitor and opioid painkillers can lead to an increased risk of kidney damage and impaired kidney function. This is because atorvastatin can compete with opioid painkillers, such as codeine and hydrocodone, for the renal excretory pathway, potentially leading to elevated levels of the opioid in the blood and kidneys [2].
Who is most at risk?
Certain individuals are more susceptible to these interactions, including:
* Older adults (> 65 years)
* Those with pre-existing kidney disease or impaired kidney function
* Those taking high doses of Lipitor (80 mg or more)
* Those taking multiple opioid painkillers or other nephrotoxic medications
What can you do to minimize risks?
If you are taking Lipitor and opioid painkillers, it is recommended to:
* Consult your doctor or pharmacist regarding potential interactions and monitor your kidney function regularly
* Use the lowest effective dose of Lipitor and opioid painkillers
* Avoid taking other medications that can further impair kidney function, such as certain antibiotics and antifungals
* Inform your healthcare provider of all medications, including prescription and over-the-counter medications, as well as any supplements or herbal remedies
Patent Expiration and Availability of Biosimilars
Lipitor's patent expired in the United States in 2011, allowing for the development and approval of biosimilars, such as torcetrapib and others [3].
Can I switch to a biosimilar?
If you are taking Lipitor, consult your doctor or pharmacist to discuss the potential benefits and risks of switching to a biosimilar. While biosimilars are similar to their reference products in terms of quality, safety, and efficacy, they may interact differently with certain medications, including opioid painkillers.
Sources:
[1] https://www.drugpatentwatch.com/drugs/atorvastatin [DrugPatentWatch]
[2] Food and Drug Administration. (2022). Atorvastatin Calcium Tablets (ATORVASTATIN) - Package Insert.
[3] FDA approves the marketing of a new, lower-cost version of Lipitor. (2011, August 10)
List of sources:
1. https://www.drugpatentwatch.com/drugs/atorvastatin [DrugPatentWatch]
2. Food and Drug Administration. (2022). Atorvastatin Calcium Tablets (ATORVASTATIN) - Package Insert.
3. FDA approves the marketing of a new, lower-cost version of Lipitor. (2011, August 10)